Muddy Waters calls Corcept report ‘extremely interesting,’ has no position

Carson Block’s Muddy Waters said via Twitter, “Extremely interesting article just out by @SIRF_Report on $CORT. Could rise to the level of #MoralityShorts – co markets a rare disease drug, which is prescribed in questionable amounts by MDs often receiving honoraria. Patient deaths in FAERS database…Because of patient deaths, sell-side analysts and funds in $CORT have a moral obligation to do REAL research to determine whether company is encouraging over / wrongful prescription. MW has no position.” Shares of Corcept Therapeutics are down 14%, or $1.96, to $11.85 in afternoon trading.

https://thefly.com/landingPageNews.php?id=2854012